purpose of review levels of dehydroepiandrosterone dhea are known to decline with agein an era of increasing use of supplements to better life the benefits of dhea in the aging female population are controversialthe goal of this article is to critically review published studies to determine if there is a role for dhea supplementation in postmenopausal womenrecent findings daily administration of oral dhea achieves serum concentrations similar to those of women in their 20sseveral observational studies have shown that lower dhea levels are associated with increased cardiovascular risk in women however interventional trials show no improvement in atherosclerosis or cardiovascular risk factors and a lowering of hdl cholesterol levelsdhea supplementation modestly increases bone mineral density in conjunction with adjuvant therapies and improves cognition in those with mildtomoderate cognitive impairment but does not affect cognition in unimpaired womenuse of intravaginal dhea but not oral dhea alleviates vaginal atrophy and improves sexual function in postmenopausal womensummary on the basis of current evidence there is no role for oral dhea supplementation in healthy postmenopausal womenwhere benefits have been shown longterm studies are needed to confirm these benefits and verify the safety profile of dhea